Has Christopher Liu, MD received payments from drug or device companies?

Yes. Drug and device makers reported $181,132 in general payments to Christopher Liu, MD across 401 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Christopher Liu, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Christopher Liu, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Christopher Liu, MD

Clinical Cardiac Electrophysiology · New York, NYNPI 1710975404

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (44.7%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Biotronik Inc. accounts for 65.2% of it on its own, with 16 other manufacturers making up the rest. Among clinical cardiac electrophysiology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$181,132in general payments, 2019–2025

Across 401 payments — averaging $451.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Biotronik Inc.$118K
Medtronic$28K
Biosense Webster, Inc.$19K
Abbott$5K
Boston Scientific$4K
Atricure, Inc.$2K
plus $4K from 11 others

$1,004,108in research payments, 2019–2025

Across 1,210 payments — averaging $829.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Biosense Webster, Inc.$463K
Medical Device Business Services, Inc.$186K
Medtronic$175K
Biotronik Inc.$167K
Abbott$14K

What the payments were for

Consulting fees$17,78610%
Speaking & faculty fees$80,90045%
Travel & lodging$59,65933%
Food & beverage$21,17612%
Education$1,4841%
Entertainment$1260%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Biotronik Inc.	196	$118,076
Medtronic(2 entities)	57	$27,941
Biosense Webster, Inc.	22	$19,358
Abbott	38	$4,874
Boston Scientific	46	$4,385
Atricure, Inc.	15	$2,263
Medical Device Business Services, Inc.	5	$1,028
Stereotaxis Inc	3	$708
EBR Systems, Inc.	6	$657
Altathera Pharmaceuticals LLC	2	$583
Impulse Dynamics (USA) Inc.	2	$281
Kestra Medical Technology Services, Inc.	2	$281
Shockwave Medical, Inc	1	$189
Acutus Medical, Inc.	1	$188
Philips North America LLC	2	$144
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$99
E.r. Squibb & Sons, L.L.C.	2	$75

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Solia$20,801
Arctic Front$19,482
BioMonitor$13,466
Carto 3 System$11,169
Carto Smarttouch$11,169
Carto CFAE$11,169
CartoSound$11,169
Acticor 7 VR-T DX$9,872
Edora 8 DR-T$8,476
Rivacor 7 DR-T$8,367
Selectra$7,779
Edora$5,719
Acticor$5,719
Rivacor$5,719
Carto 3$3,949
Sentus$3,529
Plexa$3,529
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$2,082
TENDRIL$1,613
ATRICLIP LAA EXCLUSION SYSTEM$1,236

How this compares

$181,132 in reported general payments places this provider in the 90th percentile of 214 clinical cardiac electrophysiology providers in New York.

See all clinical cardiac electrophysiology providers in New York →

Medicare billing

Part B allowed, 2024

$385,786

Medicare patients

817

Services billed

3,073

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	164	$173,193
MultaqDronedarone Hcl	29	$33,823
XareltoRivaroxaban	22	$27,412
Dofetilide	27	$7,922
Flecainide Acetate	41	$1,940
Metoprolol Succinate	53	$1,462
SotalolSotalol Hcl	58	$1,078
Amiodarone Hcl	52	$1,024
Diltiazem 24hr Er (Cd)Diltiazem Hcl	19	$477
ClopidogrelClopidogrel Bisulfate	27	$411
Diltiazem Hcl	14	$305
Amoxicillin	11	$22

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in New York

Vivek ReddyNew York$14.9M
Jacob KoruthNew York$3.7M
Srinivas DukkipatiNew York$2.7M
Amir AhmadiNew York$789K
Larry ChinitzNew York$448K
James IpNew York$347K
Nicholas SkipitarisNew York$293K
Mohit TuragamNew York$202K
David LauNew York$202K
Chirag BarbhaiyaNew York$156K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →